IHE logo

iShares U.S. Pharmaceuticals ETF (IHE)

$109.64

Quotes are delayed by 15 minutes.

1D

1W

1M

3M

6M

YTD

1Y

2Y

5Y

ALL

Key data on IHE

AUM

$1.72B

P/E ratio

26.4

Dividend yield

1.3452%

Expense ratio

0.37%

Beta

0.469595

Price on IHE

Previous close

$111.03

Today's open

$111.84

Day's range

$109.43 - $112.29

52 week range

$80.25 - $112.29

Profile about IHE

show more

Headquarters

US

Exchange

NYSE Arca

Issue type

Exchange-Traded Fund

IHE industries and sectors

Industries

Health

News on IHE

Pharmaceuticals ETF (IHE) Hits a New 52-Week High

For investors seeking momentum, iShares U.S. Pharmaceuticals ETF IHE is probably on the radar. The fund just hit a 52-week high and is up 42.76% from its 52-week low price of $77.52/share.

news source

Zacks Investment Research • Nov 11, 2026

news preview

Which Is the Better Buy: iShares' Pharma ETF IHE or First Trust's Biotech Fund FBT?

iShares U.S. Pharmaceuticals ETF has a lower expense ratio than the First Trust NYSE Arca Biotechnology Index Fund. First Trust NYSE Arca Biotechnology Index Fund maintains a more concentrated portfolio.

news source

The Motley Fool • Nov 11, 2026

news preview

ETFs in Spotlight as FDA Vision Loss Warning Meets Lilly's Sleep Apnea Win

Eli Lilly's sleep apnea breakthrough amid the FDA's vision-loss warning puts diversified healthcare ETFs in the spotlight.

news source

Zacks Investment Research • Nov 11, 2026

news preview

How to Invest in the Rise of China's Biotech: Buy U.S. Drug Stocks

Many of the hot new drug candidates in the U.S. were developed Chinese companies.

news source

Barrons • Nov 3, 2026

news preview

From Laggard to Leader: The Surprising Comeback of Healthcare

Healthcare stocks have finally stepped back into the spotlight. After spending much of the past several years in the shadow of technology and AI, the sector has quietly emerged as one of the year's more compelling comeback stories.

news source

ETF Trends • Oct 13, 2026

news preview

Better Pharma ETF: iShares IHE vs. State Street XPH

The iShares U.S. Pharmaceuticals ETF is significantly more concentrated than the State Street SPDR S&P Pharmaceuticals ETF, with Eli Lilly accounting for 23.63% of the portfolio. The iShares U.S. Pharmaceuticals ETF provides a higher dividend yield of 1.4% compared to 0.4% for the State Street SPDR S&P Pharmaceuticals ETF.

news source

The Motley Fool • Oct 10, 2026

news preview

Execution of Pharma Tariffs Brings These ETFs Into Focus

Trump's 100% pharma tariff is reshaping the drug industry. Here's how the key pharma ETFs could be affected.

news source

Zacks Investment Research • Oct 6, 2026

news preview

Should You Invest in the iShares U.S. Pharmaceuticals ETF (IHE)?

The iShares U.S. Pharmaceuticals ETF (IHE) was launched on May 1, 2006, and is a passively managed exchange traded fund designed to offer broad exposure to the Healthcare - Pharma segment of the equity market.

news source

Zacks Investment Research • Sep 15, 2026

news preview

IHE: Innovation Supports The Outlook, Valuation Limits Conviction

iShares U.S. Pharmaceuticals ETF offers concentrated exposure to US pharma, dominated by Johnson and Johnson (22.5%) and Eli Lilly and Company (20.5%). IHE benefits from structural growth in obesity therapies, robust drug pipelines, and demographic tailwinds but faces high concentration risk. Short-term catalysts include LLY's earnings momentum, FDA drug approvals, sector M&A activity, and potential interest rate improvements.

news source

Seeking Alpha • Sep 11, 2026

news preview

IHE: Large-Cap Pharma Cools After A Hot Summer

I issue a hold rating on the iShares US Pharmaceuticals ETF due to fair valuation and mounting near-term headwinds. IHE's portfolio is highly concentrated, with 43% in JNJ and LLY and top 10 holdings totaling 76%. Technical trends have turned concerning, with a recent breach of trendline support and a possible 10% correction to $97 likely through October.

news source

Seeking Alpha • Sep 10, 2026

news preview

¹ Disclosures

Get started with M1

Invest in iShares U.S. Pharmaceuticals ETF

Open an M1 investment account to buy and sell iShares U.S. Pharmaceuticals ETF commission-free¹. Build wealth for the long term using automated trading and transfers.

Invest in IHE on M1